Charles River Laboratories | CRL - Créanciers Commerciaux

Prix De L'Action
179.31
Variation Quotidienne
0.97 0.54%
Mensuellement
17.99%
Annuel
69.29%
Q2 Prévisions
170.85




Créanciers Commerciaux Changement Date
Agilent USD 602M 32M 2025-12
Align Technology USD 121.45M 4.1M 2025-12
Bio-Rad Laboratories USD 129M 200K 2025-12
Bruker USD 215.9M 31.5M 2025-12
Cardinal Health USD 39B 2.14B 2025-12
Charles River Laboratories USD 148.8M 20.82M 2025-12
Cigna USD 10.66B 1.31B 2025-12
Concord Medical Services Hldg CNY 112.19M 19.4M 2025-06
CVS Health USD 59.38B 1.56B 2025-12
Danaher USD 1.84B 147M 2025-12
Dentsply International USD 300M 32M 2025-12
Elevance Health USD 17.08B 64M 2025-12
Galapagos EUR 104.65M 4.02M 2025-12
Hologic USD 201.1M 573.5M 2025-12
Humana USD 5.72B 198M 2025-12
Illumina USD 240M 22M 2025-12
Incyte USD 1.63B 1.46B 2025-12
Intrexon USD 4.85M 3.12M 2024-06
IQVIA Holdings USD 3.75B 201M 2025-12
Laboratory Of America USD 840.8M 172.3M 2025-12
Lonza CHF 471M 3M 2024-12
McKesson USD 60.68B 255M 2025-12
Merck EUR 2.11B 182M 2025-12
Mettler Toledo International USD 266.63M 19.22M 2025-12
Novartis USD 4.46B 99M 2025-12
Pfizer USD 5.02B 142M 2025-09
Quest Diagnostics USD 1.6B 143M 2025-12
Revvity USD 185.46M 9.66M 2025-12
Thermo Fisher Scientific USD 3.62B 502M 2025-12
United Therapeutics USD 7.1M 460.9M 2025-12
UnitedHealth USD 40.18B 1.75B 2025-09
Veradigm USD 30.84M 18.23M 2022-12
Waters USD 103.78M 11.95M 2025-12
West Pharmaceutical Services USD 253.7M 2.1M 2025-12